NanJing Pharmaceutical Company Limited announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was CNY 8,789.021 million compared to CNY 8,735.682 million a year ago. Operating income was CNY 128.704 million compared to CNY 124.447 million a year ago. Net income was CNY 75.959 million compared to CNY 72.193 million a year ago. Basic earnings per share from continuing operations was CNY 0.073 compared to CNY 0.069 a year ago.